Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1991 Mar;87(3):1023-31.
doi: 10.1172/JCI115061.

Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole

Affiliations
Case Reports

Diastolic dysfunction in hypertrophic cardiomyopathy. Effect on active force generation during systole

J K Gwathmey et al. J Clin Invest. 1991 Mar.

Abstract

We tested the hypothesis that intracellular Ca++ [( Ca++]i) overload underlies the diastolic dysfunction of patients with hypertrophic cardiomyopathy. Myocardial tissue was obtained at the time of surgery or transplantation from patients with hypertrophic cardiomyopathy and was compared with control myocardium obtained from patients without heart disease. The isometric contractions and electrophysiologic properties of all myocardial specimens were recorded by standard techniques and [Ca++]i was measured with the bioluminescent calcium indicator aequorin. In contrast to the controls, action potentials, Ca++ transients, and isometric contraction and relaxation were markedly prolonged in the hypertrophic myocardium, and the Ca++ transients consisted of two distinct components. At 38 degrees C and 1 Hz pacing frequency, a state of relative Ca++ overload appeared develop, which produced a rise in end-diastolic [Ca++]i, incomplete relaxation, and fusion of twitches with a resultant decrease in active tension development. We also found that drugs with increase [Ca++]i, such as digitalis, exacerbated these abnormalities, whereas drugs that lower [Ca++]i, such as verapamil, or agents that increase cyclic AMP, such as forskolin, prevented them. These results may explain why patients with hypertrophic cardiomyopathy tolerate tachycardia poorly, and may have important implications with regard to the pharmacologic treatment of patients with hypertrophic cardiomyopathy.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Circulation. 1967 May;35(5):847-51 - PubMed
    1. Br Heart J. 1958 Jan;20(1):1-8 - PubMed
    1. Dtsch Med Wochenschr. 1976 Aug 27;101(35):1284-7 - PubMed
    1. Br Heart J. 1977 Jun;39(6):661-70 - PubMed
    1. Am J Cardiol. 1980 Jan;45(1):141-54 - PubMed

Publication types